Sarcoidosis: Social predictors of severity at presentation

European Respiratory Journal

Volumn 24, Issue 4, 2004, Pages 601-608

  Rabin, D L ^a   Thompson, B ^a   Brown, K M ^a   Judson, M A ^a   Huang, X ^a   Lackland, D T ^a   Knatterud, G L ^a   Yeager Jr , H ^a   Rose, C ^a   Steimel, J ^a   Baughman, R P ^b   Bresnitz, E A ^b   Cherniak, R ^b   Depablo, L ^b   Hunninghake, G ^b   Iannuzzi, M C ^b   Johns, C J ^b   McLennan, G ^b   Moller, D R ^b   Musson, R ^b   Newman, L S ^b   Rossman, M D ^b   Rybicki, B A ^b   Teirstein, A S ^b   Terrin, M L ^b   Winberger, S E ^b   more..

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Barriers to care; Income; Insurance; Sarcoidosis; Severity; Socioeconomic status

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DYSPNEA; FEMALE; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH INSURANCE; HISTOPATHOLOGY; HUMAN; LOWEST INCOME GROUP; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICARE; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; RADIODIAGNOSIS; SELF REPORT; SEX RATIO; SOCIAL ASPECT; SOCIAL STATUS;

ADULT; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; DEMOGRAPHY; DISTRICT OF COLUMBIA; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 6944230867     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00070503     Document Type: Article

References (32)

1. Smedley BD, Stith AY, Nelson AR, eds. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, Board on Health Sciences Policy. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care, Washington, D.C., Institute of Medicine, 2002.
2. Auerbach JA, Krimgold BK, eds. Income, socioeconomic status, and health: Exploring the relationships. Washington, D.C., National Policy Association, 2001; 161p. (NPA Report, 299).
3. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
4. Rabin DL, Richardson MS, Stein SR, Yeager H Jr. Sarcoidosis severity and socioeconomic status. Eur Respir J 2001; 18: 499-506.
5. Yeager H Jr, Rabin DL, Stein SR, et al. Pulmonary sarcoidosis: comparison of patients at a university and a municipal hospital. J Natl Med Assoc 1999; 91: 322-327.
6. Kajdasz DK, Judson MA, Mohr LC Jr, Lackland DT. Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators. Am J Epidemiol. 1999; 150: 271-278.
7. ACCESS Research Group. Design of a case control etiology study of sarcoidosis (ACCESS). J Clin Epidemiol 1999; 52: 1173-1186.
8. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr, ACCESS Research group. Defining organ involvement in sarcoidosis; The ACCESS proposed instrument. ACCESS Research Group. A Case-Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 75-86.
9. Scadding JG. Prognosis of intrathoracic sarcoidosis in England: A review of 136 cases after five years observation. BMJ 1962; 2: 1165-1172.
10. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-87.
11. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133: 97-103.
12. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA, New England Medical Center; 1993.
13. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, USA, Wiley and Sons, 1989.
14. SAS Institute Inc., SAS/STAT Users Guide, Vol. 2, 4th Edn. Cary, NC: The SAS Institute; 1989. Watson, SD. Medicaid physician participation: patients, poverty, and physician self-interest. Am J Law Med 1995; 21: 191-220.
15. US Bureau of the Census. Selected economic characteristics of persons and families, by sex and race: March, 1997. Available from: www.census.gov. Date last accessed: 11 November 2001.
16. Wayson SD. Medicaid physician participation: patients, poverty, and physician self-interest. Am J Law Med 1995; 21: 191-220.
17. Rybicki BA, Major MM, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-241.
18. Judson MA, Thompson BW, Rabin DL, et al. The diagnostic pathway to sarcoidosis. Chest 2003; 123: 406-412.
19. Kajdasz DK, Lackland DT, Mohr LC, Judson MA. A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol 2001; 11: 111-117.
20. Viegi G, Paoletti P, Prediletto R, et al. Prevalence of respiratory symptoms in an unpolluted area of northern Italy. Eur Respir J 1988; 1: 311-318.
21. Gulsvik A. Prevalence and manifestations of obstructive lung disease in the city of Oslo. Scand J Respir Dis 1979; 60: 286-296.
22. Barsky AJ, Goodson JD, Lane RS, Cleary PD. The amplification of somatic symptoms. Psychosomatic Medicine 1988; 50: 510-519.
23. Harik-Khan RI, Fleg JL, Muller DC, Wise RA. The effect of anthropometric and socioeconomic factors on the racial difference in lung function. Am J Respir Crit Care Med 2001; 164: 1647-1654.
24. De Vries J, Van Heck GL, Drent M. Gender differences in sarcoidosis: symptoms, quality of life, and medical consumption. Women Health 1999; 30: 99-114.
25. Chang B, Steimel J, Moller DR, et al. Depression in sarcoidosis. Am J Respir Crit Care Med 2001; 163: 329-334.
26. Lautenbacher S, Spernal J, Schreiber W, Krieg JC. Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med 1999; 61: 822-827.
27. Dales RE, Spitzer WO, Schechter MT, Suissa S. The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis 1989; 139: 1459-1463.
28. Zahran HS, Moriarty DG, Zack MM, Kobau R. Public health and aging: health-related quality of life among low-income persons aged 45-64 years: United States, 1995-2001. MMR weekly-DHHS, CDC. 52: 1120-1124.
29. Gold M, Franks P, Erickson P. Assessing the health of the nation: the predictive validity of a preference-based measure and self-rated health. Medical Care 1996; 32: 163-177.
30. Cox C, Donohue J, Brown C, Kataria Y, Judson M. Health-related quality of life of persons with sarcoidosis. Chest 2004; 125: 997-1004.
31. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996; 51: 238-247.
32. Pietinalho A, Tukiainen P, Haahtela T, Persson T, Selroos O. Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest 2002; 121: 24-31.